irinotecan hydrochloride trihydrate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
MEDITAB IRINOTECAN irinotecan hydrochloride trihydrate 100 mg / 5 mL injection vial AUST R: 167202Active ingredients:
irinotecan hydrochloride trihydrate
Dosage form:
Injection
Sponsor:
Cipla Australia Pty Ltd
Phone:
03 9696 4413
|
Deletion from market:
12 Jun 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Manufacturing
Management action:
An alternative brand is available.
|